Related references
Note: Only part of the references are listed.Towards more effective acetylcholinesterase inhibitors: a comprehensive modelling study based on human acetylcholinesterase protein-drug complex
Abdulilah Ece
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Energetically optimized pharmacophore modeling to identify dual negative allosteric modulators against group I mGluRs in neurodegenerative diseases
Sitrarasu Vijaya Prabhu et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Combinatorial peptide library screening for discovery of diverse α-glucosidase inhibitors using molecular dynamics simulations and binary QSAR models
Adriano Mollica et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus
Muhammad Tahir Ul Qamar et al.
SCIENTIFIC REPORTS (2019)
Cryo-EM density map fitting driven in-silico structure of human soluble guanylate cyclase (hsGC) reveals functional aspects of inter-domain cross talk upon NO binding
Rana Rehan Khalid et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
Annika Rosengren et al.
LANCET GLOBAL HEALTH (2019)
Discovery of Novel μ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening
Giulio Poli et al.
MOLECULES (2019)
Regulation of PDE5 expression in human aorta and thoracic aortic aneurysms
Valeriana Cesarini et al.
SCIENTIFIC REPORTS (2019)
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
Emanuele Di Angelantonio et al.
LANCET GLOBAL HEALTH (2019)
The Molecular Organization of Human cGMP Specific Phosphodiesterase 6 (PDE6): Structural Implications of Somatic Mutations in Cancer and Retinitis Pigmentosa
Arooma Maryam et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations
Shalini Saxena et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Improving Accuracy, Diversity, and Speed with Prime Macrocycle Conformational Sampling
Dan Sindhikara et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Inexpensive Method for Selecting Receptor Structures for Virtual Screening
Zunnan Huang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective
Pierre Bobin et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Role of sGC-dependent NO signalling and myocardial infarction risk
Jana Wobst et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets
F. Ahmad et al.
ORAL DISEASES (2015)
The ChEMBL bioactivity database: an update
A. Patricia Bento et al.
NUCLEIC ACIDS RESEARCH (2014)
Assessing the Performance of 3D Pharmacophore Models in Virtual Screening: How Good are They?
Rodolpho C. Braga et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies
Abdulilah Ece et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
Michael M. Mysinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design, Synthesis, and Pharmacological Evaluation of Monocyclic Pyrimidinones as Novel Inhibitors of PDE5
Guan Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Thiophene inhibitors of PDE4: Crystal structures show a second binding mode at the catalytic domain of PDE4D2
Jacob L. Nankervis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Anti-platelet therapy: phosphodiesterase inhibitors
Paolo Gresele et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
PDE1 isozymes, key regulators of pathological vascular remodeling
Stefan Chan et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
Devleena Shivakumar et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution
Jeremy R. Greenwood et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension
Patrick Crosswhite et al.
JOURNAL OF HYPERTENSION (2010)
CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes
Alberto Del Rio et al.
MOLECULAR BIOSYSTEMS (2010)
Structure-Based Virtual Ligand Screening: Recent Success Stories
Bruno O. Villoutreix et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis
Noeris K. Salam et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Novel Approach for Efficient Pharmacophore-Based Virtual Screening: Method and Applications
Oranit Dror et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide
Sameer Kawatkar et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation
Kathryn Loving et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK2 inhibitors in cancer therapy
Vinicius Barreto da Silva et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2008)
Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil
Huanchen Wang et al.
MOLECULAR PHARMACOLOGY (2008)
Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects
C. Foresta et al.
EYE (2008)
Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan
Saman K. Hashmi et al.
PLOS ONE (2007)
Evaluating virtual screening methods: Good and bad metrics for the early recognition problem
Jean-Francois Truchon et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Phosphodiesterase inhibitors
V Boswell-Smith et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Benchmarking sets for molecular docking
Niu Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Combining testosterone and PDE5 inhibitors in erectile dysfunction: Basic rationale and clinical evidences
Emanuela A. Greco et al.
EUROPEAN UROLOGY (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Compartmentation of cyclic nucleotide signaling in the heart - The role of cyclic nucleotide phosphodiesterases
Rodolphe Fischmeister et al.
CIRCULATION RESEARCH (2006)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Multiple conformations of phosphodiesterase-5 - Implications for enzyme function and drug development
Huanchen Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium
R Hambleton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells
J Wharton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and camp signaling in cells of the cardiovascular system
DH Maurice
FRONTIERS IN BIOSCIENCE (2005)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Utility of homology models in the drug discovery process
A Hillisch et al.
DRUG DISCOVERY TODAY (2004)
Structural basis for the activity of drugs that inhibit phosphodiesterases
GL Card et al.
STRUCTURE (2004)
Crystal structure of human phosphodiesterase 3B: Atomic basis for substrate and inhibitor specificity
G Scapin et al.
BIOCHEMISTRY (2004)
Cyclic GMP-dependent protein kinases and the cardiovascular system
R Feil et al.
CIRCULATION RESEARCH (2003)
Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system
DH Maurice et al.
MOLECULAR PHARMACOLOGY (2003)
Structure validation by Cα geometry:: φ,ψ and Cβ deviation
SC Lovell et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Identification of interaction sites of cyclic nucleotide phosphodiesterase type 3A with milrinone and cilostazol using molecular modeling and site-directed mutagenesis
W Zhang et al.
MOLECULAR PHARMACOLOGY (2002)
On the role of the crystal environment in determining protein side-chain conformations
MP Jacobson et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Structure-based generation of a new class of potent Cdk4 inhibitors:: New de novo design strategy and library design
T Honma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B
W Zhang et al.
PROTEIN SCIENCE (2001)
Evidence for expression and function of phosphodiesterase type 5 (PDE-V) in rat resistance arteries
LJ Sampson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Conserved amino acids in metal-binding motifs of PDE3A are involved in substrate and inhibitor binding
W Zhang et al.
BLOOD (2000)
Share Paper
